Briefing
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma
In a 1,076-patient real-world surveillance series, circulating TTMV-HPV DNA (NavDx) was the first indication of recurrence in most positive cases, with a reported PPV of 95%.
- Design: Evidence level 2
- Assay: Not named in the abstract
Clin Cancer ResPubMed 35576437DOI 10.1158/1078-0432.CCR-22-0562